We will also be participating in very high growth market segments and finally I would like to spend a little bit of time talking about the developing markets related to life sciences, where there is a convergence of automation and cryogenics, two core technical capabilities for the company that provide an opportunity to manage the cold compound and biological storage of samples that are essential to the development of personalized medicines.So we have a very unique spot in a rapidly growing market, taking core capabilities from the semiconductor and adjacent space in to life sciences. This is an exciting area for the company and I think we have made great strides just one year in to the business.
Brooks Automation's CEO Presents At Citi Technology Conference (Transcript)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts